2-(2-Diaethylamino-aethoxy)-benzylalkohol | 1890-57-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-(2-Diaethylamino-aethoxy)-benzylalkohol
• 英文别名: [2-(2-Diethylamino-ethoxy)-phenyl]methanol；[2-[2-(diethylamino)ethoxy]phenyl]methanol
• CAS: 1890-57-9
• 化学式: C₁₃H₂₁NO₂
• mdl: MFCD11149630
• 分子量: 223.315
• InChiKey: BRQPGDZGIIEVKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.538
• 拓扑面积：
  32.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(2-Diaethylamino-aethoxy)-benzylalkohol 在 氯化亚砜 作用下， 生成 2-(2-Diethylaminoethoxy)-benzylchlorid
  参考文献：
  名称：

  Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X7 antagonists

  摘要：

  Synthesis and biological evaluation of a novel class of substituted N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine derivatives resulted in the identification of potent P2X(7) antagonists. These compounds were assayed for activity at both the human and rat P2X(7) receptors. On the benzyl moiety, a variety of functional groups were tolerated, including both electron-withdrawing and electron-donating substituents. Ortho-substitution on the benzyl group provided the greatest potency. The ortho-substituted analogs showed approximately 2.5-fold greater potency at human compared to rat P2X(7) receptors. Compounds 12 and 38 displayed hP2X(7) pIC(50)s > 7.8 with less than 2-fold difference in potency at the rP2X(7). (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.04.024
• 作为产物：
  描述：

  2-[2-(二乙胺基)乙氧基]苯甲醛 在 氢氧化钾 、 聚合甲醛 作用下， 以 甲醇 为溶剂， 生成 2-(2-Diaethylamino-aethoxy)-benzylalkohol
  参考文献：
  名称：

  174.杂环系列中的某些抗菌化合物。第四部分 苯并噻唑系列的非光敏碱性醚

  摘要：

  DOI：

  10.1039/jr9650000954

文献信息

• Amino-tetrazole analogues and methods of use
  申请人：Carroll A. William

  公开号：US20060052374A1

  公开（公告）日：2006-03-09

  A compound having Formula (I) or Formula (II) is disclosed as an P2X 7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R 1 , R 2 , R 3 , R 4 , and R 5 , are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X 7 are also disclosed.

  本文披露一种化合物，其化学式为（I）或（II），作为P2X7拮抗剂，其中A、B、C、Y、Y、Z、m、v、R1、R2、R3、R4和R5如描述中所定义。同时，本文还披露了治疗P2X7调节的疾病或病症的方法和组合物。
• Amino-Tetrazoles Analogues and Methods of Use
  申请人：Carroll William A.

  公开号：US20080171733A1

  公开（公告）日：2008-07-17

  A compound having Formula (I) or Formula (II) is disclosed as an P2X 7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R 1 , R 2 , R 3 , R 4 , and R 5 , are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X 7 are also disclosed.

  本发明揭示了一种具有公式（I）或公式（II）的化合物，作为P2X7拮抗剂，其中A，B，C，Y，Y，Z，m，v，R1，R2，R3，R4和R5如描述中所定义。还揭示了用于治疗受P2X7调节的疾病或病况的方法和组合物。
• Amino-tetrazoles analogues and methods of use
  申请人：Carroll A. William

  公开号：US20070049584A1

  公开（公告）日：2007-03-01

  A compound having Formula (I) or Formula (II) is disclosed as an P2X 7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R 1 , R 2 , R 3 , R 4 , and R 5 , are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X 7 are also disclosed.

  公开了一种化合物，其化学式为（I）或化学式（II），作为P2X7拮抗剂，其中A，B，C，Y，Y，Z，m，v，R1，R2，R3，R4和R5如说明中所定义。还公开了治疗受P2X7调节的疾病或病状的方法和组合物。
• AMINO-TETRAZOLES ANALOGUES AND METHODS OF USE
  申请人：Carroll William A.

  公开号：US20120329772A1

  公开（公告）日：2012-12-27

  A compound having Formula (I) or Formula (II) is disclosed as an P2X 7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R 1 , R 2 , R 3 , R 4 , and R 5 , are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X 7 are also disclosed.

  公开了一种具有式(I)或式(II)的化合物作为P2X7拮抗剂，其中A、B、C、Y、Y、Z、m、v、R1、R2、R3、R4和R5如描述中所定义。还公开了用于治疗受P2X7调节的疾病或病情的方法和组合物。
• US8546374B2
  申请人：——

  公开号：US8546374B2

  公开（公告）日：2013-10-01